Finance

Explore the landscape of Finance in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Finance to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Pfizer's Oral Ritlecitinib Meets Primary Endpoints in Phase III Nonsegmental Vitiligo Trials – Largest‑Ever Oral Systemic Program Clears Path for Global Filings
CompanyDrug

Pfizer’s Oral Ritlecitinib Meets Primary Endpoints in Phase III Nonsegmental Vitiligo Trials – Largest‑Ever Oral Systemic Program Clears Path for Global Filings

Pfizer Inc. (NYSE: PFE) announced that ritlecitinib (brand name Litfulo), an oral kinase inhibitor, met the primary endpoints in two Phase III trials in nonsegmental vitiligo, with data presented at…

Qyuns Therapeutics' Oturkibart Delivers Late‑Breaking Phase III Data in Prurigo Nodularis at EADV 2026 – IL‑4Rα Antibody Beats Placebo on Itch and Lesion Clearance

Qyuns Therapeutics’ Oturkibart Delivers Late‑Breaking Phase III Data in Prurigo Nodularis at EADV 2026 – IL‑4Rα Antibody Beats Placebo on Itch and Lesion Clearance

Abogen Biosciences Strikes Licensing and Option Deal with Novartis for ABO2203 – Up to $7.2 Billion to Advance the First mRNA‑Encoded T‑Cell Engager in Autoimmune Disease

Abogen Biosciences Strikes Licensing and Option Deal with Novartis for ABO2203 – Up to $7.2 Billion to Advance the First mRNA‑Encoded T‑Cell Engager in Autoimmune Disease

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Milestone Biotechnologies Secures Nearly 100 Million Yuan in Series A+ Funding
Company

Milestone Biotechnologies Secures Nearly 100 Million Yuan in Series A+ Funding

Prime Gene Therapeutics Secures Over RMB300 Million in Series B Financing
CompanyDeals

Prime Gene Therapeutics Secures Over RMB300 Million in Series B Financing

Maxvax Biotechnology Secures RMB 200 Million in Convertible Bonds Financing
CompanyDeals

Maxvax Biotechnology Secures RMB 200 Million in Convertible Bonds Financing

Shinva Medical Instrument to Acquire Stake in Wuhan Zhongzhi Biotechnologies for IVD Expansion
CompanyDeals

Shinva Medical Instrument to Acquire Stake in Wuhan Zhongzhi Biotechnologies for IVD Expansion

Reforgene Medicine Secures Hundreds of Millions in Financing for Gene Therapy Expansion
CompanyDeals

Reforgene Medicine Secures Hundreds of Millions in Financing for Gene Therapy Expansion

GenFleet Therapeutics Submits IPO Application to HKEX, Backed by CITIC Securities
Company

GenFleet Therapeutics Submits IPO Application to HKEX, Backed by CITIC Securities

Overwhelming Shareholder Support for Hengrui Pharmaceuticals' H-Share IPO
Company

Overwhelming Shareholder Support for Hengrui Pharmaceuticals’ H-Share IPO

Dynamiker Biotechnology Receives Approval for IPO on Beijing Stock Exchange
Company

Dynamiker Biotechnology Receives Approval for IPO on Beijing Stock Exchange

Show More